semaglutide step 1 : Treatment Effect in People with Obesity – My Endo Consult 🎉 Great news! Tirzepatide EZ

A 2024 study published in JAMA Ophthalmology reported that patients with Type 2 diabetes who took semaglutide-containing medications had more than a fourfold higher risk for developing non-arteritic anterior ischemic optic neuropathy (NAION) compared with patients not on a GLP-1 agonist

Additional factors influencing injection site pain include needle gauge, injection technique, injection speed, and individual patient characteristics such as subcutaneous tissue thickness and pain sensitivity

By mimicking the GLP-1 hormone, Wegovy controls sugar levels and aids in weight management

Semaglutide is a glucagon-like peptide (GLP-1) receptor agonist